No specific pharmacological information is provided

This product is a macrolide antibiotic, which has an inhibitory effect on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Peptostreptococcus, and Propionibacterium acnes. In addition, it also has an inhibitory effect on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.

Aminoglycoside antibiotics may have an inhibitory effect on Helicobacter pylori and exert a local bactericidal effect in the stomach

It blocks the nerve endings on the surface of the damaged mucosa, blocking the stimulation of the lesions on the central nervous system and thus quickly relieving pain.

Gentomycin in this product is an aminoglycoside antibiotic, which may have the effect of inhibiting Helicobacter pylori and exerting a local bactericidal effect in the stomach; procaine can block the nerve endings on the surface of damaged mucosa, blocking the stimulation of lesions on the central nervous system and thus quickly relieving pain.

Azithromycin is a 15-membered ring macrolide antibiotic that has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. It mainly binds to the 50S subunit of the bacterial ribosome and inhibits RNA-dependent protein synthesis.